| Address |
1980 Rue Michelin Laval, H7L 5C2 Canada |
|
| Address type | Registered Office Address | |
| Address province | Quebec |
| Corporation ID | 7160364 | |
| Business number | 810312223 | |
| Status | Active | |
| ACT | Canada Business Corporations Act | |
| Anniversary date | 04/21/2009 | |
| Last annual filing | 2026 | |
| Data verified | 10/31/2026 |
Location: Statistics Canada, Open Database of Addresses (Open Government Licence – Canada).
| Name | Effective date | Type | Current |
|---|---|---|---|
| BIOMOMENTUM INC. | 04/21/2009 | Corporate Name | true |
last updated: 2026-11-05
Individuals who own, control or direct 25% or more of the shares, or have control in fact over the corporation, as reported to Corporations Canada.
reported to the registry: 04/21/2026 · last checked: 11/05/2026
| Type of corporation | Non-distributing corporation with 50 or fewer shareholders |
| Annual filing period (MM-DD) | 04-21 to 06-20 |
| Last annual meeting | 11/06/2025 |
| Year | Annual return |
|---|---|
| 2026 | Filed |
| 2025 | Filed |
| 2024 | Filed |
last checked: 11/05/2026
2 federal grants and contributions in 2022 with a total value of $423,000.
| Start date | Department and program | Value |
|---|---|---|
| 12/22/2022 |
Canada Economic Development for Quebec Regions The Regional Economic Growth Through Innovation Program (REGI) (contribution) 600070717 Acquisition of equipment: the project aims to improve the productivity and increase the production capacity of a company that specializes in the manufacture of devices and the provision of biomechanical measurement testing services. |
$300,000 |
| 07/15/2022 |
National Research Council Canada Industrial Research Assistance Program – Contributions to Firms (contribution) Design of a new pre-clinical model of post-traumatic osteoarthritis in rats. Many companies aim to develop injectable products to prevent or delay the development of certain diseases. These products must be tested in pre-clinical models in order to prove their efficacy and then obtain regulatory approvals to begin clinical trials. The objective of this project is to develop... |
$123,000 |
Source: Government of Canada, proactive disclosure of grants and contributions. Contains information licensed under the Open Government Licence – Canada.
| Date | Type | Section |
|---|---|---|
| 04/21/2009 | Incorporation |
| Meeting date | Type of corporation | Year of filing |
|---|---|---|
| 05/09/2016 | Non-distributing corporation with 50 or fewer shareholders | 2017 |
| 05/09/2016 | Non-distributing corporation with 50 or fewer shareholders | 2016 |
| 02/10/2015 | Non-distributing corporation with 50 or fewer shareholders | 2015 |